Want to see NL:PHIA full AI Analyst Report?
Top Page
Koninklijke Philips N.V.
(PHIA)
Select Model
Select Model
Rating:61Neutral
Price Target:
€26.00
▲(2.56% Upside)
Action:Reiterated
Date:05/09/26
The score is primarily supported by improving TTM profitability and stronger free cash flow, indicating a meaningful operational recovery. However, the overall rating is held back by weak top-line momentum and historically volatile results, plus a technically weak setup (price below key moving averages and negative MACD) and a high P/E that raises the bar for continued earnings improvement.
Positive Factors
Improved profitability and cash generation
Trailing-twelve-months profitability has recovered to positive EBIT and net income while operating cash flow and free cash flow strengthened. Sustained cash generation increases resilience, funds servicing and R&D investment, and supports deleveraging or strategic reinvestment over the medium term.
Negative Factors
Weak top-line momentum
Revenue weakness means recent earnings recovery is driven more by margin and efficiency than sustainable growth. Without durable organic top-line expansion, scaling services and software is harder, and reliance on cost cures raises execution risk over the coming quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Improved profitability and cash generation
Trailing-twelve-months profitability has recovered to positive EBIT and net income while operating cash flow and free cash flow strengthened. Sustained cash generation increases resilience, funds servicing and R&D investment, and supports deleveraging or strategic reinvestment over the medium term.
Read all positive factors
Koninklijke Philips N.V. (PHIA) vs. iShares MSCI Netherlands ETF (EWN)
Market Cap
€23.25B
Dividend Yield3.73%
Average Volume (3M)1.33M
Price to Earnings (P/E)23.6
Beta (1Y)0.96
Revenue GrowthN/A
EPS GrowthN/A
CountryNL
Employees67,247
SectorGeneral
Sector StrengthN/A
IndustryMedical - Devices
Share Statistics
EPS (TTM)1.02
Shares Outstanding982,884,770
10 Day Avg. Volume1,198,930
30 Day Avg. Volume1,333,770
Financial Highlights & Ratios
PEG Ratio-0.11
Price to Book (P/B)2.01
Price to Sales (P/S)1.24
P/FCF Ratio24.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€26.91Price Target Upside6.15% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering12
EPS Forecast (FY)1.54
Revenue Forecast (FY)€17.93B
Koninklijke Philips N.V. Business Overview & Revenue Model
Company Description
Koninklijke Philips N.V. operates as a leading global healthcare technology enterprise with a presence across North America and numerous international markets. Its operations are organized into three primary divisions: Diagnosis & Treatment Busine...
How the Company Makes Money
Philips makes money mainly by selling healthcare equipment, related software, and associated services to healthcare providers and consumers. A large portion of revenue comes from hospital and clinical customers purchasing capital equipment such as...
Koninklijke Philips N.V. Financial Statement Overview
Summary
Income Statement
68
Positive
Balance Sheet
72
Positive
Cash Flow
70
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.64B | 17.83B | 18.02B | 18.17B | 17.83B | 17.16B |
| Gross Profit | 7.97B | 8.06B | 7.77B | 7.45B | 7.19B | 7.17B |
| EBITDA | 2.72B | 2.77B | 1.85B | 1.04B | -280.00M | 1.73B |
| Net Income | 970.00M | 896.00M | -702.00M | -466.00M | -1.61B | 3.32B |
Balance Sheet | ||||||
| Total Assets | 27.27B | 26.94B | 28.98B | 29.41B | 30.69B | 30.96B |
| Cash, Cash Equivalents and Short-Term Investments | 2.59B | 2.79B | 2.40B | 1.87B | 1.18B | 2.31B |
| Total Debt | 8.10B | 8.09B | 7.49B | 7.69B | 8.20B | 6.98B |
| Total Liabilities | 15.85B | 15.96B | 16.93B | 17.34B | 17.41B | 16.49B |
| Stockholders Equity | 11.39B | 10.96B | 12.01B | 12.03B | 13.25B | 14.44B |
Cash Flow | ||||||
| Free Cash Flow | 1.91B | 903.00M | 893.00M | 1.49B | -979.00M | 866.00M |
| Operating Cash Flow | 2.29B | 1.17B | 1.57B | 2.14B | -173.00M | 1.63B |
| Investing Cash Flow | -986.00M | -747.00M | -573.00M | -636.00M | -1.49B | -3.67B |
| Financing Cash Flow | 133.00M | 107.00M | -496.00M | -848.00M | 500.00M | -2.35B |
Koninklijke Philips N.V. Technical Analysis
Positive
25.35
Price Trends
22.98
Positive
23.33
Positive
23.30
Positive
Market Momentum
0.38
Negative
54.36
Neutral
41.79
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NL:PHIA, the sentiment is Positive. The current price of 25.35 is above the 20-day moving average (MA) of 23.77, above the 50-day MA of 22.98, and above the 200-day MA of 23.30, indicating a bullish trend. The MACD of 0.38 indicates Negative momentum. The RSI at 54.36 is Neutral, neither overbought nor oversold. The STOCH value of 41.79 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NL:PHIA.
Koninklijke Philips N.V. Peers Comparison
UnderperformOutperform
Sector (55)
NL:PHIA
Koninklijke Philips N.V.
24.06
4.26
21.53%
NL:PHARM
Pharming Group
1.20
0.34
39.28%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.